Remarkable results from trials into a new drug have given hope to thousands of Irish people who suffer from an agonising medical condition, rheumatoid arthritis.

Clinical trial results in Britain described as “striking and exciting” could lead to new treatment options for rheumatoid arthritis.

Marks & Spencer was today braced for a fresh clash with investors over boardroom pay as a succession of blue-chip firms prepare for stormy annual meetings on the issue.